• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. KIT MMT-7745X IPRO2 SYSTEM CLINICAL; GLUCOSE OXIDASE, GLUCOSE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. KIT MMT-7745X IPRO2 SYSTEM CLINICAL; GLUCOSE OXIDASE, GLUCOSE Back to Search Results
Model Number MMT-7745X
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypoglycemia (1912)
Event Date 11/28/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.No conclusion can be drawn at this time.We therefore consider this report complete to the best of our knowledge.
 
Event Description
It is estimated that 13%¿20% of older people with dementia also have coexisting diabetes.Over the coming decades, this will pose a significant healthcare burden, especially in a worldwide expectation that by 2045, 629 million people with be living with diabetes and 125 million people will be living with dementia by 2050.Newer technologies, such as continuous glucose monitoring (cgm), have gained momentum in the management of diabetes, in particular in children and younger adults.This is now accompanied by a rapidly growing interest towards research studies of cgm in older people.A systematic review of studies using cgm in older people found that hypoglycaemic episodes were occurring in 28%¿65% of participants with most of those episodes (80%) being asymptomatic.Some participants spent up to 2 hours per day in the hypoglycaemic range.The review reported that older people found cgm use to be acceptable, with potential improvements in health-related well-being.This feasibility study aimed to estimate the important parameters for the sample size calculation for a full trial; no sample size calculation was undertaken at this stage.Researchers aimed to recruit up to 20 participants.This was a size that the research team considered to be pragmatic and sufficient as indicative quantitative data on which to base the sample size for a full trial.At commencement of this feasibility study, a cgm device (name omitted) was licensed for use in children and adults and available direct to consumers via the internet or from pharmacies.Eligible participants were 65 or older with type 1 or type 2 diabetes mellitus.They needed to be on glucose-lowering medication (not diet or metformin only), have an abbreviated mini-mental test (amt) score equal or less than 8 (out of 10) or already have a formal diagnosis of dementia.Use of the amt was mandated as a screening tool for memory problems in the hospital policy.In addition, a 2019 japanese study investigated the use of blinded cgm (medtronic ipro2) in older people in an outpatient setting in japan.Out of 326 participants, 7 used cgm.Asymptomatic hypoglycaemic episodes occurred in five out of the seven cgm users.It is potentially feasible for older people with diabetes and memory problems to operate a cgm device that requires users to conduct intermittent scans.However, the added benefit of real-time transmission cgm devices that do not require active scanning needs to be explored further in this group of patients.
 
Manufacturer Narrative
Supplemental report created for the initial mdr report that was submitted inappropriately as the device did not contribute to an adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
KIT MMT-7745X IPRO2 SYSTEM CLINICAL
Type of Device
GLUCOSE OXIDASE, GLUCOSE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
ceiba norte ind. park #50 road
juncos 00777 -386
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
ceiba norte ind. park #50 road
juncos 00777 -386
Manufacturer Contact
gerwin de graaff
ceiba norte ind. park #50 road
juncos 00777--386
8185464805
MDR Report Key9520224
MDR Text Key173892089
Report Number2032227-2019-138014
Device Sequence Number1
Product Code CGA
Combination Product (y/n)N
Reporter Country CodeUK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMMT-7745X
Device Catalogue NumberMMT-7745X
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-